Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
Kosehasanogullari
Seyfullah Gorkem
SG
Akdede
Berna
B
Akvardar
Yildiz
Y
Akan
Mert
M
Tunca
Zeliha
Z
D000747:Anemia, Hypochromic / Q000150:complications; D018692:Antimanic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D001971:Bromocriptine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D015600:Glasgow Coma Scale; D006801:Humans; D007037:Hypothyroidism / Q000150:complications; D018020:Lithium Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000150:complications / Q000503:physiopathology*; D011014:Pneumonia / Q000150:complications; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000150:complications; D017086:beta-Thalassemia / Q000150:complications
D018692:Antimanic Agents; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D001971:Bromocriptine; D018967:Risperidone